A carregar...
EGFR protein expression using a specific intracellular domain antibody and PTEN and clinical outcomes in squamous cell lung cancer patients with EGFR-tyrosine kinase inhibitor therapy
PURPOSE: The aim of this research was to examine the molecular and clinical features that are related with EGFR-tyrosine kinase inhibitor (EGFR-TKI) efficacy in previously treated patients with squamous cell carcinoma of the lung (SCCL). MATERIALS AND METHODS: This retrospective study included 67 SC...
Na minha lista:
Publicado no: | Onco Targets Ther |
---|---|
Main Authors: | , , , , , , , |
Formato: | Artigo |
Idioma: | Inglês |
Publicado em: |
Dove Medical Press
2016
|
Assuntos: | |
Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4998034/ https://ncbi.nlm.nih.gov/pubmed/27578983 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S107291 |
Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|